Facon T, Moreau P, Baker R, Min C-K, Leleu X, Mohty M, Karlin L, Armstrong NM, Tekle C, Schwab S, Risse M-L, Martin T. Isatuximab plus carfilzomib and dexamethasone in patients with early <i>versus</i&gt; late relapsed multiple myeloma: IKEMA subgroup analysis. Haematologica 2024;109(2):604-616; https://doi.org/10.3324/haematol.2023.283073.